AVTE - Aerovate Therapeutics, Inc. Stock Price, Fair Value and News

$2.79+0.02 (+0.72%)

Delayed as of 22 Apr 2025, 11:02 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

AVTE Price Action

Last 7 days

3.3%

Last 30 days

11.1%

Last 90 days

9.8%

Trailing 12 Months

-87.3%

AVTE RSI Chart

AVTE Valuation

Market Cap

80.3M

Price/Earnings (Trailing)

-1.15

EV/EBITDA

-0.67

Price/Free Cashflow

-1.13

MarketCap/EBT

-1.15

AVTE Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AVTE Fundamentals

AVTE Earnings

Earnings (TTM)

-69.6M

Earnings Growth (Yr)

73.4%

Earnings Growth (Qtr)

66.56%

AVTE Profitability

Return on Equity

-91.1%

Return on Assets

-86.68%

Free Cashflow Yield

-88.68%

AVTE Investor Care

Shares Dilution (1Y)

3.89%

Diluted EPS (TTM)

-2.44

Revenue & Growth

About Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

CEO	Mr. Timothy P. Noyes M.B.A.
WEBSITE	https://aerovatetx.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	43

Aerovate Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Aerovate Therapeutics, Inc.? What does AVTE stand for in stocks?

AVTE is the stock ticker symbol of Aerovate Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aerovate Therapeutics, Inc. (AVTE)?

As of Mon Apr 21 2025, market cap of Aerovate Therapeutics, Inc. is 80.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVTE stock?

You can check AVTE's fair value in chart for subscribers.

Is Aerovate Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether AVTE is over valued or under valued. Whether Aerovate Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Aerovate Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVTE.